Names and Identifiers

• • dinoprost
  • prostaglandin F2-alpha
  • Prostaglandin F2A
  • 9,11,15-trihydroxyprosta-5,13-dien-1-oicacid
  • amoglandin
  • cyclosin
  • dinolytic
  • enzaprost
  • enzaprostf
  • glandin
  • Prostaglandin F2alpha
  • tromethamine
  • Prostaglandin F2α
  • Prostaglandin F2α Lipid Maps MS Standard
  • (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-((S)-(E)-3-hydroxyoct-1-enyl)-cyclopentyl]hept-5-enoic acid
  • [3H]-PGF2alpha
  • Dinprost
  • Glandin N
  • panacelan
  • PGF2ALPHA
  • PGF2α
  • (5Z,9a,11a,13E,15S)-9,11,15-Trihydroxyprosta-5,13-diene-1-oic acid
  • Cerviprost
  • Enzaprost F
  • Protamodin
  • l-PGF2-alpha
  • l-Prostaglandin F2-alpha
  • Dinoprostum
  • Dinoprosta
  • Prostin F2alpha
  • Prostin F2-alpha
  • PGF2-alpha
  • PGF2 alpha
  • PGF-2alpha
  • Prostarmon F
  • Prostaglandin F2 alpha
  • 9alpha,11alpha-PGF2
  • PGF2
  • Prostaglandin F(sub 2a)
  • Dinoprostum [INN-Latin]
  • Dinoprosta [INN-Spanish]
  • U 14583
  • Prostaglandin F2
  • Din
  • DINOPROST [HSDB]
  • 9a,11a-PGF2
  • (+)-Prostaglandin F2a
  • HMS1361K16
  • NCGC00160385-04
  • Prostaglandin F2.alpha.
  • PDSP2_000079
  • Tox21_111777
  • SCHEMBL24292
  • B7IN85G1HY
  • 7-(3, 5-dihydroxy-2-(3-hydroxyl-1-octenyl) cyclopentyl)-5-heptenoic acid
  • NCGC00160385-05
  • BML1-F08
  • (E,Z)-(1R,2R,3R,5S)-7-(3,5-Dihydroxy-2-((3S)-(3-hydroxy-1-octenyl))cyclopentyl)-5-heptenoic acid
  • U-14583
  • (5Z,13E,15S)-9alpha,11alpha,15-trihydroxyprosta-5,13-dien-1-oic acid
  • 1ST11386
  • BDBM50035622
  • BRN 4153898
  • DB12789
  • A830494
  • CHEMBL815
  • Dinoprost [USAN:INN:BAN:JAN]
  • Prostaglandin F2-alpha, racemic mixt.
  • Prostin F 2 alpha
  • 5-Heptenoic acid, 7-(3,5-dihydroxy-2-(3-hydroxy-1-octenyl)cyclopentyl)-, l-
  • 5-Heptenoic acid, 7-(3,5-dihydroxy-2-(3-hydroxy-1-octenyl)cyclopentyl)-, (1R-(1alpha(Z),2beta(S*,E),3alpha,5alpha))-
  • Dinaprost
  • 15(R)-Prostaglandin F2 alpha
  • LMFA03010002
  • NCGC00160385-06
  • 5-HEPTENOIC ACID, 7-(3,5-DIHYDROXY-2-(3-HYDROXY-1-OCTENYL)CYCLOPENTYL)-, dl-
  • (5z,9alpha,11alpha,13e,15s)-9,11,15-trihydroxyprosta-5,13-dienoic acid
  • (E,Z)-(1R,2R,3R,5S)-7-[3,5-Dihydroxy-2-[(3S)-(3-hydroxy-1-octenyl)]cyclopentyl]-5-heptenoic acid
  • 9S,11R,15S-trihydroxy-5Z,13E-prostadienoic acid
  • Dinoprostum (INN-Latin)
  • Prosta-5,13-dien-1-oic acid, 9,11,15-trihydroxy-, (5Z,9alpha,11alpha,13E,15S)-
  • F2alpha, Prostaglandin
  • Prosmon (TN)
  • PGF2.alpha.
  • (5Z,9alpha,11alpha,13E,15S)-9,11,15-trihydroxyprosta-5,13-dien-1-oic acid
  • dl-Prostaglandin F2-alpha
  • 15-epi PGF2alpha
  • (Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((S,E)-3-hydroxyoct-1-enyl)-cyclopentyl)-hept-5-enoic acid
  • Prostaglandin-F2alpha
  • (5Z,9alpha,11alpha,13E,15S)-9,11,15-Trihydroxyprosta-3,13-dien-1-oic acid
  • U-14,583
  • HMS2089F11
  • CCG-208257
  • (5Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]hept-5-enoic acid
  • G02AD01
  • 7-[3,5-Dihydroxy-2-(3-hydroxy-1-octenyl)cyclopentyl]-5-heptenoic acid
  • NCGC00160385-01
  • F2 alpha, Prostaglandin
  • Prostaglandin F2alpha, dl-
  • BSPBio_001494
  • (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]cyclopentyl]hept-5-enoic acid
  • GTPL1884
  • P1885
  • HY-12956
  • (5Z,9alpha,11alpha,13E,15S)-9,11,15-Trihydroxyprosta-5,13-dienoate
  • DINOPROST [USAN]
  • CCRIS 4253
  • (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-{(E)-(3S)-3-hydroxy-1-octenyl}-cyclopentyl]-5-heptenoic acid
  • PGF2a
  • 9,11,15-Trihydroxyprosta-5,13-dien-1-oic acid
  • AMY30098
  • C00639
  • PXGPLTODNUVGFL-YNNPMVKQSA-N
  • Prosta-5,13-dien-1-oic acid, 9,11,15-trihydroxy-, (5Z,9-alpha,11-alpha,13E,15S)-(+-)-
  • (5Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1E,3S)-3-hydroxyoct-1-en-1-yl)cyclopentyl)hept-5-enoic acid
  • DINOPROST [JAN]
  • 5-Heptenoic acid, 7-(3,5-dihydroxy-2-(3-hydroxy-1-octenyl)cyclopentyl)-, (+-)-
  • (5Z,13E)-(15S)-9alpha,11alpha,15-Trihydroxyprosta-5,13-dienoate
  • UNII-B7IN85G1HY
  • NCGC00160385-02
  • (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((S,E)-3-hydroxyoct-1-en-1-yl)cyclopentyl)hept-5-enoic acid
  • EX-A4115A
  • CS-4232
  • HMS3648N11
  • IDI1_033964
  • Prosmon
  • CHEBI:15553
  • DINOPROST [INN]
  • SR-01000946457
  • 9alpha,11beta PGF2
  • Dinoprost; Prostaglandin F2a; PGF2alpha
  • BRN 2225571
  • HMS3402K16
  • DTXSID9022946
  • Dinoprost (JP17/USAN/INN)
  • Dinoprosta (INN-Spanish)
  • 9,11,15-Trihydroxy-(5Z,9a,11a,13E,15S)-prosta-5,13-dien-1-oic acid
  • SR-01000721847-2
  • HSDB 3315
  • (+)-Prostaglandin F2alpha
  • SR-01000721847
  • PGF2alpha-[d4]
  • (+-)-PGF2-alpha
  • (+-)-PGF2alpha
  • DINOPROST (MART.)
  • HMS1791K16
  • alpha, PGF2
  • DINOPROST [WHO-DD]
  • 23518-25-4
  • NS00124545
  • DTXCID602946
  • 7-(3,5-Dihydroxy-2-(3-hydroxy-1-octenyl)cyclopentyl)-5-heptenoic acid
  • PROSTAGLANDIN F2.ALPHA. [MI]
  • D00081
  • CAS-551-11-1
  • PGF2-alpha racemic mixt.
  • Q421375
  • 551-11-1
  • SR-01000946457-1
  • HMS1989K16
  • SR-01000721847-4
  • 13535-33-6
  • MFCD00135231
  • DINOPROST [MART.]
  • AKOS030526160
  • EN300-21689745
  • Prosta-10,13-dien-1-oic acid, 9,11,15-trihydroxy-, (5Z,9.alpha.,11.alpha.,13E,15S)
  • AS-56892
  • (Z)-7-[(1R,2R,3R,5S)-3,5-bis(oxidanyl)-2-[(E,3S)-3-oxidanyloct-1-enyl]cyclopentyl]hept-5-enoic acid
  • Dinoprost?
  • BRD-K81672972-001-03-1
  • A12628
  • Dinoprost
  • +expand
• • MDL： MFCD00135231
  • Inchi： 1S/C20H34O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,15-19,21-23H,2-3,5-6,8-11,14H2,1H3,(H,24,25)/b7-4-,13-12+/t15-,16+,17+,18-,19+/m0/s1
  • InChI Key： PXGPLTODNUVGFL-YNNPMVKQSA-N
  • SMILES： O[C@H]1C[C@H]([C@H](/C=C/[C@H](CCCCC)O)[C@H]1C/C=C\CCCC(=O)O)O

Computed Properties

Experimental Properties